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ABSTRACT 
 
Background: The antimalarial prescription response that community health 
workers (CHWs) and hospital workers in Africa give when faced with the new 
rapid diagnostic testing technologies for malaria. 
Objectives: To understand why health workers subsequent treatment patterns 
are not always in alignment with the diagnostic result, especially when faced with 
negative test results- they frequently prescribe anti-malaria drugs despite these 
negative results.  
Data Sources: Articles stemming from PubMed, the WHO, and the CDC. In 
reference to the PubMed articles used for the presentation of published results, 
the articles range from 2007-2012 and were found via PubMed using the MeSH 
search terms Africa, malaria, rapid, Malaria/diagnosis, health, community, 
residence characteristics, hospital, and hospitals.  
Eligibility Criteria: The searches only looked at clinical trials and reviews. Then 
articles were narrowed down to ones that discussed rapid diagnostic testing 
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along with treatment given for both RDT positive and RDT negative results, the 
results, and the treatment that they were given by a caregiver after knowing the 
results of the test. In the end, 6 clinical trials involving community health workers 
and 11 clinical trials involving hospital workers underwent evaluation. 
Conclusions: There is a discrepancy of perceived and actual malaria cases. 
While health care providers give antimalarial prescriptions in response to positive 
RDT results in essentially a 1:1 ratio, it is only when faced with a negative RDT 
result that adherence begins to falter. Trained clinicians and health care workers 
are more reluctant to adopt the changed protocols that RDT brings because of 
the ingrained attitude that fever equates to malaria even when presented with 
evidence to the contrary. On the other hand, there is high adherence in 
community health workers since they have less medical background knowledge 
to overcome. In order to remedy this, improved training regimens need to be 
enacted such as providing alternate diagnoses when presented with a negative 
rapid diagnostic testing result, especially in the format of a pictorial cascade 
diagram. 
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INTRODUCTION 
 
Prevalence of Malaria 
According to the Centers for Disease Control and Prevention (CDC), 
malaria is found in areas where Anopheles mosquitos can survive and multiply 
and where malaria parasites can complete their growth cycle of extrinsic 
incubation period in mosquitos. At temperatures below 20oC (68o F), the most 
severe malaria parasite cannot complete its growth cycle in the Anopheles 
mosquito and cannot be transmitted. Subsequently, transmission is more intense 
and year-round in tropical areas such as Sub-Saharan Africa and parts of 
Oceania. Despite sufficiently high temperatures, transmission will not occur at 
high altitudes or in deserts, excluding desert oases (CDC-Centers for Disease 
Control and Prevention, 2010a). The reason malaria cannot thrive in deserts is 
because mosquitos lay their eggs in water and therefore malaria will be more 
prevalent in a given area during the rainy season. 
From the World Malaria Report 2012 by the World Health Organization 
(WHO), it is estimated that there were 219 million cases of malaria (estimate 
ranges from 154-289 million) with an estimated 660,000 deaths (estimate ranges 
from 610,000-971,000) in 2010. Up to 3.3 billion people live in areas at risk of 
malaria transmission in 106 countries and territories. In 2010, 80% of those 
estimated cases occurred in 17 countries with the Democratic Republic of the 
Congo, India, and Nigeria accounting for 40% of all estimated malaria cases. 
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80% of malaria deaths in 2010 occurred in just 14 countries with the Democratic 
Republic of the Congo and Nigeria accounting for 40% of all estimated deaths 
due to malaria (see Figure 1). Overall, 80% of malaria cases and 90% of deaths 
are estimated to occur in the WHO Africa Region with children under five and 
pregnant women being most severely affected (WHO. Global Malaria 
Programme, 2012). The reason for the prevalence of malaria deaths in these 
areas is that malaria mortality rates are highest in countries with a lower Gross 
National Income per capita, countries that have a larger proportion of the 
population living in poverty, as defined by living on less than US $1.25 per 
person per day, and countries with large populations in rural areas. (WHO. 
Global Malaria Programme, 2012). 
The total international and domestic funding committed towards malaria 
control is estimated to be US $2.3 billion in 2011. However, that number is 
substantially less than the US $5.1 billion necessary per year to achieve 
universal access to malaria interventions across the world. Fortunately, there has 
been an increase in international spending towards malaria regions every year, 
rising from less than US$100 million in 2000 to US $1.66 billion in 2011, and US 
$1.84 billion in 2012 (see Figure 2)  (WHO. Global Malaria Programme, 2012). 
Much of the increased international funding was driven by the priority that the 
Bush administration in the US placed on health care and development in 
international relations, especially Africa (Tierney, 2011). 
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Figure 1: Cumulative Proportion of Global Estimated Deaths in Endemic Countries. Taken 
from Global Malarial Programme 2012 by the WHO. 
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Figure 2: International Funding for Malaria Control (Past and Projected) 2000-2015. Taken 
from Global Malarial Programme 2012 by the WHO.
 
 
The Malaria Parasite and Life Cycle 
Malaria in humans is caused by five species of parasites from the genus 
Plasmodium; the species include P. falciparum, P. vivax, P. ovale, P. malariae, 
and P. knowlesi. Of these, malaria caused by P. falciparum is the most deadly 
and predominates in Africa, P. vivax remains less dangerous but exists on a 
more global scale, and the latter three infect humans much less frequently. 
(WHO. Global Malaria Programme, 2012).The Plasmodium malaria parasite has 
female Anopheles mosquitos and humans as hosts and has a distinct cycle of 
growth and multiplication in each (Neptune, 2011). 
 In Anopheles mosquitos, the mosquitos pick up blood stage parasites 
(“gametocytes”) during a blood meal and after 10-18 days the infectious 
parasites (“sporozoites”) are found in the salivary glands of the mosquito. The 
mosquito does not suffer from the presence of the malaria parasites (CDC-
Centers for Disease Control and Prevention, 2010b). The mosquito acts as a 
vector since it carries the disease from one human to another. In humans, 
Anopheline mosquitos transmit sporozoites from infected to uninfected humans 
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through their bite with saliva via the human’s dermis so that the sporozoites 
rapidly infect the hepatocytes (CDC-Centers for Disease Control and Prevention, 
2010b). After the parasite multiplies, the hepatocytes rupture to release scores of 
parasites that then infect erythrocytes and induce the blood stage. The blood 
stage causes the clinical symptoms associated with malaria since the parasite 
also multiplies within the erythrocyte causing them to hemolyse and release 
daughter parasites (“merozoites”), inducing cytokine release (Taylor et. al 2010). 
A more detailed description of the malaria cycle and growth in humans and 
mosquitos is available in Figure 3. 
 
Clinical Presentation of Malaria 
Clinical symptoms occur 7 to 14 days after a bite from an infected 
mosquito due to the need for the parasite to transit through the liver. Anemia and 
pallor is caused by hemolysis, dyserythropoiesis, and extra splenic clearance of 
both damaged and uninfected erythrocytes. Fevers and rigors occur due to the 
cytokine release due to hemolysis, symptoms that prove flu-like in nature. 
Splenomegaly and hepatomegaly are caused by damaged erythrocytes and 
cellular debris that enlarge the sinusoids of the liver and spleen. Nausea, 
vomiting, headache, acidosis, renal failure, hypoglycemia, and thrombocytopenia 
also develop from multifactorial causes (Taylor et al., 2010). 
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Figure 3: Malaria Parasite Life Cycle in Humans and Mosquitos. A female malaria-
infected Anopheles mosquito inoculates sporozoites into the human host during a blood meal (1). 
In the liver stage, sporozoites infect hepatocytes (2) and mature into schizonts (3) that rupture to 
release merozoites (4). After replication in the liver, called exo-erythrocytic schizogony (A), there 
is multiplication in the erythrocytes, called erythrocytic schizogony (B). In the blood stage, the 
merozoites infect red blood cells (5) then the immature ring stage trophozoites mature into 
schizonts that release merozoites (6). Some parasites then go on to differentiate into sexual 
erythrocytic stages as gametocytes (7). Anopheles mosquitos ingest these gametocytes, both 
male (microgametocytes) and female (macrogametocytes), during a blood meal (8) and the 
parasites’ multiplication in the mosquito is known as the sporogonic cycle (C). Inside the stomach 
of the misquote the microgametes penetrate the macrogametes to produce zygotes (9), those 
zygotes develop into ookinetes after becoming motile and elongated (10) in order to invade the 
midgut wall of the mosquito where they develop into oocysts (11). The oocysts grow, rupture, and 
release sporozoites which enter the mosquito’s salivary glands which allow the cycle to begin 
again when the mosquito bites a human. Taken from the CDC Malaria section on biology (CDC-
Centers for Disease Control and Prevention, 2010b). 
 
 
The clinical syndrome that evolves depends on the interplay among the 
infecting parasite species, the immune status of the host, and the timeliness of 
the use of antimalarial drugs. Non-immune patients such as children and 
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travelers manifest with an undifferentiated febrile illness with fluctuating 
paroxysms of fevers and rigors, malaise, headache, myalgias, arthralgias, pallor, 
mild jaundice, tender hepatosplenomegaly, anemia, and thrombocytopenia. If 
infected with P. falciparum these non-immune patients may manifest life-
threatening syndromes such as cerebral malaria, which is preceded by altered 
consciousness, seizures, or non-focal dysfunction of the central nervous system. 
Other severe disease manifestations include severe anemia, hypoglycemia, 
acidosis, respiratory distress, shock, and acute renal fire. On the other hand, 
adult patients in endemic areas who have developed partial immunity to malaria 
parasites due to repeated infection have reduced intensity and severity of the 
disease (Taylor et al., 2010). 
 
Diagnosis 
The diagnosis of malaria is necessary to allow people to detect malaria 
when suspected due to patients’ symptoms in order to treat the malaria or to 
delve into other causes of their symptoms such as pneumonia. It is imperative 
that malaria is recognized promptly and treated to restore the health of the 
patient and to limit the spread of malaria via mosquitos in the area. Additionally, 
one must know that there is a slight tendency for over diagnosis of malaria in 
people who live in malaria endemic regions: a person may have the malaria 
parasite in their system due to recently getting over an infection or because they 
may have enough immunity to protect them from the full-blown malaria illness 
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even if they are infected. Therefore, the presence of malaria parasites in endemic 
regions does not definitely mean that their symptoms are caused by malaria, it 
could be another disease. 
 
Clinical Diagnosis 
Clinical diagnosis is based on the patient’s symptoms during a physical 
examination. Clinical findings should receive confirmation through a laboratory 
test for malaria, especially since the first symptoms of malaria such as elevated 
temperature, perspiration, and tiredness are nonspecific. Additionally, the 
associated first symptoms of fever, chills, sweats, nausea and vomiting, 
headaches, and muscle pains are found in many other diseases like influenza 
and common viral infections. The more severe symptoms are more indicative of 
malaria such as coma, severe anemia, respiratory difficulties, and confusion.  A 
health-care provider should perform a complete blood count and a routine 
chemistry panel to determine if the malaria is uncomplicated or severe based on 
the tests ability to detect severe anemia, hypoglycemia, hyperbilirubinemia, renal 
failure, and acid-base disturbances (CDC-Centers for Disease Control and 
Prevention, 2012). Despite the inconclusive results of this form of diagnosis 
alone, this has been the main way that developing countries have diagnosed 
malaria cases throughout the years. This method of diagnosis leads to massive 
over-treatment of malaria. 
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Rapid Diagnostic Testing 
A rapid diagnostic test (RDT) involves immunologic 
(immunochromatographic) test kits that detect antigens derived from malaria 
parasites. A blood specimen from the patient is applied to a sample pad on the 
test card along with some reagents. An immunochromatographic strip assay 
involves blood being applied to one end of the nitrocellulose strip to allow the 
specimen to mix with lysing agents, a buffer solution, and labeled anti-
Plasmodium indicator antibody. Then, the liquid mixture migrates down the strip 
to an area where capture antibodies are already fixed in lines on the strip surface 
and which detect parasite antigens or indicator antibodies (Wilson, 2012). 
Currently, RDTs can detect two antigens: an antigen specific to P. 
falciparum and another antigen that is common to all 4 human Plasmodium 
species. RDTs usually come in a dipstick or cassette format, return a result in 2-
20 minutes, and indicate patient infection by looking at specific bands on the test 
card window. If infected, it determines whether it is P. falciparum or the other 3 
species, see Figure 4 (CDC-Centers for Disease Control and Prevention, 2012). 
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Figure 4: A Guide to the Interpretation of RDT Test Results. Specifically, the Paracheck Pf 
Device Rapid Test that is the most popular of the RDT tests for P. falciparum. Image A represents 
the control line and P. falciparum (Pf) line, image B a negative result, image C two positive results 
(it is positive even if the Pf line is faint). Image D represents an invalid result where no control line 
appears and the test must be done again. Taken from the FIND Diagnostics webpage 
(“Paracheck Pf Device Rapid Test for Malaria (Ver. 3) (30301025),” 2012). 
 
The use of RDTs is increasing (from 20% in 2005 to 27% in 2011) along 
with the overall percentage of suspected malaria cases that receive a 
parasitological test- that latter number increased from 68% globally in 2005 to 
77% in 2011. In Africa specifically, it rose from 20% in 2005 to 47% in 2011, 
mainly because of the use of RDTs which accounted for 40% of all the cases 
tested in Africa in 2011 (WHO. Global Malaria Programme, 2012). In 2004, 
Zambia was the first sub-Saharan country to use RDTs, followed by Senegal in 
2006; today several countries use it. The WHO recommends laboratory-
confirmed diagnosis to treat malaria and different agencies are now trying to 
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steer away from presumptive treatment to using laboratory-based diagnosis, 
especially since  there is a trend of malaria decline in Africa (D’Acremont et al., 
2011). The implementation of RDTs requires rigorous procedures to 
train/supervise providers and to obtain RDTs while enacting quality assurance. 
Furthermore, the use of RDTs in different settings should ensure that RDTs 
reduce over-diagnosis, overconsumption of antimalarials, and prevent patient 
suffering (D’Acremont et al., 2011). On June 3rd, 2007 the U.S. Food and Drug 
Administration (FDA) approved BinaxNOW® Malaria as the first RDT for use in 
the United States to be used by hospital and commercial laboratories, but not by 
individual clinicians nor patients; it remains the only RDT approved for use in the 
United States (CDC-Centers for Disease Control and Prevention, 2012). 
RDTs have a high sensitivity, low specificity, high positive predictive value, 
and high negative predictive value. The low specificity of RDTs can sometimes 
result in difficulty detecting very low levels of parasite and therefore can give a 
false negative, however, generally such a low level of parasite does not cause 
severe symptoms in people frequently exposed to malaria in malaria endemic 
areas. However, non-immune individuals may be symptomatic at very low 
parasitic densities (CDC-Centers for Disease Control and Prevention, 2010c). 
In Mtove et. al (2011) the sensitivity (probability that a test will indicate a 
positive for the disease) for the RDT Paracheck™ was very high at 97.5% and 
the specificity (fraction of those without disease who will have a negative result) 
was poor at 65.3%. However, the sensitivity of Paracheck™ was lower in 
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detecting infections with <2,000 parasites/μl and especially infections with <200 
parasites/μl. False positives were significantly associated with pre-admission use 
of antimalarial drug, absence of current fever, and non-typhi Salmonella 
bacteremia. Poor specificity is likely due to Histidine-Rich Protein II (HRP-2) 
persistence following a recent parasite clearance (Mtove et al., 2011). In 
Chinkhumba et al. (2010), the RDTs used had a high sensitivity: First response 
malaria (92%), Paracheck (91%), and ICT diagnostics (90%). However, the 
RDTs had a low specificity: First response malaria (42%), Paracheck (68%), and 
ICT diagnostics (54%) (Chinkhumba et al., 2010). 
In Kahama-Maro et al. (2011), the RDTs used had a high sensitivity of 
97%, high specificity of 96.8%, positive predictive value (proportion of people that 
test positive that have the disease) of 79.2% and negative predictive value 
(proportion that test negative that don’t have the disease) of 99.6%. The 
investigators recommended RDT use over microscopy due to microscopy’s poor 
positive predictive value of 2.8% (Kahama-Maro et al., 2011). In Ly et al. (2010), 
the sensitivity, specificity, positive predictive value, and negative predictive value 
of RDT Paracheck were respectively 100.0%, 98.3%, 80.0%, and 100.0%. This 
study involved 189 consultations of clinically suspected malaria cases in Senegal 
(Ly et al., 2010). 
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Microscopy Diagnosis 
The use of blood smear patterns under light microscopy can indicate the 
presence of malaria.  A clinician takes a drop of the patient’s blood, stains the 
specimen (usually with the Giemsa stain) to make the parasite look distinct, and 
then spreads it out onto a microscope slide. The quality of this technique 
depends on the quality of the reagents, the microscope, and the laboratory 
specialist (CDC-Centers for Disease Control and Prevention, 2012). 
An illustration of the potential erythrocyte stages that one may see when 
looking at a blood smear of P. falciparum is available in Figure 5; the other 
human infecting strains of Plasmodium look different but have the same general 
progression of the malaria parasite (CDC-Centers for Disease Control and 
Prevention, 2012). Although microscopy results under a highly trained 
diagnostician frequently proves better than RDT results and should be used in 
combination with RDTs, the quality needed to efficiently utilize this diagnostic tool 
proves difficult in most areas of Africa due to lack of constant electricity, lack of 
reagents, lack of skilled manpower, and high cost. In fact, many clinicians are 
aware of the fact that operational conditions of microscopy are low (Reyburn et 
al., 2007). Under the best of conditions sensitivity is no better than 75-90% and 
can be as low as 50% in some settings (Wilson, 2012). 
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Figure 5: Plasmodium falciparum Blood Stage Parasites in Thin Blood Smears with 
Microscopy. Normal red blood cell (1), ring-stage trophozoites (2-10), trophozoites (11-18), 
schizonts (19-25), ruptured schizont (26), mature macrogametocytes (27, 28), mature 
microgametocytes (29, 30). An illustration from the book The Primate Malarias seen via the CDC 
website section called DPDx (GR Coatney et. al, 1971). 
 
Molecular Diagnosis 
 An alternative method that is slightly more sensitive than smear 
microscopy is detecting parasite nucleic acids with polymerase chain reaction 
(PCR). Unfortunately, PCR takes more time and is frequently not available 
quickly enough to establish diagnosis of malaria for timely treatment. It is best 
used to confirm malaria positive results generated by microscopy or RDT (CDC-
Centers for Disease Control and Prevention, 2012). 
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Serology 
 Serology involves detecting antibodies against malaria parasites using 
indirect immunofluorescence or enzyme-linked immunosorbent assay. Therefore, 
serology is used to detect past malaria exposure and not current infection for 
clinical purposes since one has to wait weeks for antibodies to develop (CDC-
Centers for Disease Control and Prevention, 2012). 
 
Prevention 
Effective prevention methods include vector control using insecticide-
treated nets, indoor residual spraying, larval control, chemoprevention for the 
most vulnerable populations of pregnant women and infants, confirmation of 
malaria diagnosis for every suspected case, and timely disease management 
with the appropriate anti-malarial medication. Unfortunately, many malaria strains 
are becoming resistant to insecticide use. The malaria vectors can be resistant to 
some insecticides as evidenced by Figure 6 and are also becoming resistant to 
the anti-malarial drugs themselves. (WHO. Global Malaria Programme, 2012). 
Another way to help limit the severity of malarial illness in infants is by 
breastfeeding: the mother is able to pass on antimalarial antibodies to their child 
through the breast milk. 
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Figure 6: Countries with Ongoing Malaria Transmission Where Resistance to Insecticide 
Has Been Identified in at Least One of Their Major Malaria Vectors. Dark brown represents 
countries with ongoing malaria transmission and resistance to at least one insecticide, light brown 
represents countries with ongoing malaria transmissions and no reports of insecticide resistance, 
light grey represents not applicable, white represent certified malaria-free and/or no ongoing local 
transmission for over a decade. Taken from Global Malarial Programme 2012 by the WHO. 
 
Treatment 
Malaria control necessitates prompt diagnosis and treatment; treatment 
should occur within 24 hours of onset in order to help stymy the potential 
progression of malaria from an uncomplicated case to a severe case of malaria. 
Artemisinin-based combination therapies (ACTs) were endorsed by the 
World Health Assembly in 2007 as the first-line treatment for malaria caused by 
P. falciparum over oral artemisinin-based monotherapies since the 
monotherapies foster the spread of resistance to artemisinin. Since this 
recommendation in recent years, treatment courses of ACT have been 
increasing in the region, growing from 11 million in 2005, go 76 million in 2006, 
and 278 million in 2011. Artemether-lumefantrine (AL) accounted for the largest 
percentage of ACTs given (77%) with artesunate + amodiaquine being the 
second most used ACT. 77% of the ACTs were used in Africa. On the other 
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hand, P. vivax malaria should be treated with chloroquine or again with ACTs if 
that P. vivax strain is resistant to chloroquine. Additionally, P. vivax should be 
combined with a 14-day course of primaquine in order to prevent relapse (WHO. 
Global Malaria Programme, 2012). 
Other treatments that are active against the parasite forms in the blood 
include atovaquone-proguanil (Malarone®), mefloquine (Lariam®), quinine, 
quinidine, doxycycline (in combination with quinine), clindamycin (in combination 
with quinine), and primaquine (active against the dormant parasite liver forms 
and prevents malaria relapse). If a person has a severe form of malaria where 
they can no longer take oral medications, they should receive the treatment via 
continuous intravenous infusion (CDC-Centers for Disease Control and 
Prevention, 2010c). Additionally, some countries in Africa have national 
guidelines indicating sulphadoxine-pyrimethamine as the antimalarial drug of 
choice (Ishengoma et al., 2011). 
A reason for rampant presumptive treatment when seeing febrile patients 
despite new guidelines is due to the old WHO guideline from the 1980s involving 
the Integrated Management of Childhood Illness (IMCI) decision chart which was 
implemented as a method to improve the survival rate of children under five with 
fever when fewer diagnostics tools were available. Unfortunately, presumptive 
treatment started to spread beyond the group of high-risk children to children 
over five and adults, to low endemicity areas, and to facilities where diagnostic 
tools were actually available. Therefore, almost all fevers were treated with 
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antimalarial leading to massive over diagnosis of malaria (D’Acremont et al., 
2011). Since then, parasite prevalence has gone down, with presence of 
Plasmodium falciparum in sub-Saharan Africa in children between the ages of 
two and ten decreasing from 37% in 1985-1999 to 17% in 2000-2007 
(D’Acremont et al., 2009). This may be partly due to effective chemoprophylaxis 
for children in malaria endemic areas who received an antimalarial but did not 
have malaria by reducing the human infectious reservoir, however, this idea may 
no longer be viable since malaria transmission rates are lower (Bastiaens et al., 
2011). 
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SPECIFIC AIMS 
 
As per the guidance of Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) (Liberati et al., 2009), this review decided to 
provide details throughout including context, objectives, data sources, study 
selection with participants and interventions, study appraisal and synthesis 
methods, results, and limitations . 
 
Context 
The response that community health workers (CHWs) and hospital 
workers have towards the new rapid diagnostic testing technologies. 
 
Objectives 
To understand why health workers subsequent treatment patterns are not 
always in alignment with the diagnostic result, especially when faced with 
negative test results- they frequently prescribe anti-malaria drugs.  
The overall purpose of this paper is to examine the interpretation of rapid 
diagnostic testing results by CHWs and hospital workers and the subsequent 
treatment that they give in relation to that test result. 
This paper goes one step further from determining the ability of RDTs to 
detect malaria and to examine the actions taken by CHWs and hospital workers 
in response to the RDTs, especially when those persons decide to prescribe 
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antimalarials in the absence of positive diagnostic results. This paper’s main goal 
is not to determine the efficacy of RDTs over other malaria diagnostic kits or to 
evaluate the efficacy among specific RDT brands. 
 
Data Sources 
Articles stemming from PubMed, the WHO, and the CDC. In reference to 
the PubMed articles used for the presentation of published results, the articles 
range from 2007-2012 and were found via PubMed using MeSH search terms 
Africa, malaria, rapid, Malaria/diagnosis, health, community, residence 
characteristics, hospital, and hospitals.  
 
Study Selection 
These searches also only looked at clinical trials and reviews. Then 
articles were narrowed down to ones that discussed rapid diagnostic testing 
along with treatment given for both RDT positive and RDT negative results, the 
results, and the treatment that they were given by a caregiver after knowing the 
results of the test. The study was narrowed down to articles referring to people 
living in Africa (not travelers in Africa), the RDT interpretations by trained health 
care providers and not by i.e. families, and the restriction on age was that this 
study eliminated articles talking mainly about RDTs in relation to prenatal fetuses 
in pregnant mothers. In the end, 6 clinical trials involving CHWs and 11 clinical 
trials involving hospital workers underwent evaluation. 
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POTENTIAL PROBLEMS DUE TO OVER PRESCRIPTION 
 
One should test all suspected cases of malaria and only those with 
confirmed malaria cases should be treated with antimalarial medicines. 
Compared to today’s actual practice, the need for malaria treatment would be 
dramatically reduced (WHO. Global Malaria Programme, 2012). Improving 
malaria diagnosis with RDTs is a proposed approach to reducing the 
overtreatment of malaria, especially with the new implementation of ACTs 
(Hamer et al., 2007). Use of antimalarials alone leads to adverse drug reactions 
and mistrust of ACTs may develop if ACTs are used inappropriately for viral or 
bacterial diseases and then don’t work (D’Acremont et al., 2009). 
 
Resistance 
The parasite has a relatively quick reproductive period and resistance has 
developed to early and commonly prescribed drugs like chloroquine and anti-
folates, along with resistance to newer generations of drugs (Tierney, 2011). 
Parasite resistance to artemisinin has been detected in many countries to 
multiple ACTs, therefore, studies have been enacted to observe treatment using 
non-artemisinin-based combination of atovaquone-proguanil (WHO. Global 
Malaria Programme, 2012). 
There is a concern for the reduced susceptibility of P. falciparum parasites 
to ACTs, especially from studies that report allelic selection of malaria parasites 
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after AL overuse (Bastiaens et al., 2011). There has been a growth of resistance 
to older antimalarial drugs and newer ACTs have been developed to help combat 
that, but ACTs cost 10 times that of the previous set of antimalarial drugs 
(Reyburn et al., 2007). 
 
Missed Diagnosis of Other Febrile Causing Diseases 
 Over diagnosis of malaria in febrile cases causes clinicians to miss 
diagnosing other febrile causing disease. Malaria and pneumonia account for 
40% of mortality among children less than five years of age in sub-Saharan 
Africa and have much symptom overlap (Ukwaja et. al, 2011). Therefore, it is 
imperative to try to distinguish the two diseases because one requires 
antimalarials while the other generally requires an antibiotic and an antipyretic. 
Fevers not attributable to malaria in malaria endemic regions are 56% 
acute respiratory infections, 10% gastroenteritis, 6% urinary infections, 3% 
typhoid, 3% other documented infections, and 22% fever of unknown origin (D’ 
Acremont et al., 2010). Additionally, 68% of the acute respiratory infections and 
31% of the gastroenteritis cases are associated with viruses that will not respond 
to antibiotics (D’ Acremont et al., 2010). Therefore, they will persist longer than 
malaria cases treated with an antimalarial drug. 
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Side Effects 
The most commonly encountered side effects to antimalarials are mild. 
Most antimalarial can cause gastrointestinal disturbances including nausea, 
vomiting, diarrhea, loss of appetite, and mild weight loss. They can affect the 
brain by causing lightheadedness, dizziness, and headaches. Other general side 
effects include rashes, coughs, and general weakness (Herriman, 2010). 
Doxycycline is a weak antimalarial that can also cause an increased sensitivity to 
sun and increased vaginal yeast infections. Contraindications exist in children 
because doxycycline forms deposits in growing bones and teeth (Weld, 2010). 
Antimalarials also cause severe and life threatening side effects. Those 
psychiatric in nature most frequently arise from the drug mefloquine that 
commonly causes hallucinations, nightmares, seizures, feelings disconnected 
from oneself, thoughts of suicide, and other confused behavior. Therefore, 
people with psychiatric illness and epilepsy have contraindications from use of 
mefloquine; these psychiatric symptoms can even last after the drug course has 
ended. Chloroquine can also cause psychological symptoms from mild 
depression to severe psychiatric disturbances, create cardiac arrhythmias, and 
cause a severe drop in blood pressure. After chronic use, renal disease, disease 
of the bone, and disease of the heart muscle can occur from chloroquine (Sage 
Weld, 2010). Several antimalarials, such as quinine, cause hemolytic anemia 
when a patient has a Glucose-6-phosphate dehydrogenase deficiency. Quinine 
can also cause cardiac problems such as heart arrhythmia’s, weak pulse, and 
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EKG irregularities. Malarone can cause severe skin rashes, bleeding disorders, 
and uncontrolled diarrhea and vomiting. It can even cause the life threatening 
skin disease Stevens-Johnson syndrome where the epidermis separates from 
the dermis. Pregnant women have contraindications against most antimalarials 
due to the association with potential birth defects (Herriman, 2010). Quinidine 
can cause ringing in the ears, hearing loss, mild depression, EKG changes that 
can lead to fatal arrhythmias. After high doses, quinidine commonly causes 
hypoglycemia and less commonly causes blindness, deafness, paralysis, 
destruction of platelets, and hepatitis (Weld, 2010). Overall, antimalarials can be 
lethal if taken in high dosages, partially because the medication absorbs rapidly. 
There are few side effects associated with ACTs. 
   
Costs  
Excessive costs for malaria will ensue due to over prescription. Therefore, 
in 2010 the WHO said that due to over prescription of antimalarials, before 
malaria treatment there should first be a confirmation of malaria presence in a 
person. In addition, due to the high costs of the new ACTs, especially AL, in 2003 
the Global Fund for HIV/AIDS, Tuberculosis, and Malaria decided that improved 
malaria diagnosis proved necessary to rationalize the use of ACTs in peripheral 
clinics (Hamer et al., 2007). Additionally, lower health status contributes to the 
economic burden that malaria can pose on society (Neptune, 2011). 
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Parasitological diagnosis and treatment with ACTs is cost-effective in all 
current malaria-endemic situations as long as the RDT test result is taken into 
account (D’Acremont et al., 2009). Therefore, if the RDT result does not receive 
consideration then the RDT diagnosis used to prescribe ACT treatment approach 
will not result in cost-effectiveness.  
In the study Hamer et al. (2007), if 27% of RDT negative patients receive 
ACTs, as occurred in their study, the use of RDTs does not appear cost-effective. 
They utilized the estimate of US $0.5 per RDT and US $1 per course of AL, the 
cost savings is only US $0.33 per patient ($330 per 1,000 patients) (Hamer et al., 
2007). Therefore, a greater adherence to RDTs and/or a lowered cost of AL need 
to occur. 
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COMMUNITY HEALTH WORKERS AND RAPID DIAGNOSTIC TESTS 
 
Study Designs, Results, and How Training Affected Adherence 
Hamer et. al (2012) performed a cluster-randomized controlled trial with 
specific guidelines on how to manage RDT results, involving community-based 
management of malaria and/or non-severe pneumonia in children under the age 
of 5 in rural Zambia. The intervention arm trained CHWs to treat RDT positive 
cases with AL and non-severe pneumonia with amoxicillin, and to refer severe 
cases of pneumonia to a health facility while the control CHWs group treated all 
febrile children with AL, and referred any form of pneumonia. 95.9% of the 1,017 
children enrolled received RDTs, in the intervention arm 94-100% of the time the 
malaria or pneumonia was correctly identified and treated for with amoxicillin, AL, 
and an antipyretic (see table 1). 90% of febrile children with a negative RDT 
result recovered with only an antipyretic (Hamer et al., 2012).  
 
Table 1: Appropriate Prescription Given Based on CHW Diagnosis. Taken from Hamer et al., 
2012. 
 
That strong data point of 90% recovering without malarial treatment may 
help assuage the fears that hospital workers and CHWs have by not giving a 
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treatment to febrile children. A theory as to why CHWs are more likely adhere to 
the test results is because they do not have as much background knowledge and 
will more likely follow the guidelines that others provide for them in evaluating 
rapid diagnostic testing. In addition, in this particular case the training was novel 
in that few programs trained CHWs to help treat both pneumonia and malaria, 
both of which are the two leading causes of mortality in children under 5 
worldwide. It helps to make CHWs adhere to not providing antimalarials to RDT 
negative patients since they still have tools to treat patients for the other diseases 
that they learned about in training.  
Masaninga et. al (2012) was a retrospective study of community-level 
introduction of RDT use in Livingstone District, Zambia where RDT introduction in 
2007 use led to a large decline in reported malaria cases and antimalarial 
consumption. Malaria declined by 96.6% from 30,723 cases in 2007 to just 1,022 
total cases in 2009 (23 confirmed, 999 unconfirmed), mortality due to malaria 
declined from 60 cases in 2004 to zero cases in 2008, malaria-like fever 
declined, ACT use declined from 12,550 courses per quarter to 822 courses per 
quarter, and quinine consumption declined. The exact RDT positive rate was not 
well documented over the years of the study, but the authors sought trends by 
comparing data from the study period to more recent data. 2009 records show 
that 3,605 suspected cases were tested with RDTs or microscopies, garnering 
119 positive results, while in 2011 2,926 suspected malaria cases were tested 
and 72 were positive. 
28  
The training in this program involved CHWs who received training to treat 
with ACT only if the patient had an RDT positive result and to refer patients with 
significant fever and RDT negative results. Prior to this, the region mainly used 
symptom-based diagnosis due to limited microscopy (only 12.5% of their 1,750 
public health facilities) (Masaninga et al., 2012). Training helped adherence since 
it stated that most RDT results would result in negative results since malaria 
stands as a highly over diagnosed disease. However, there was still malaria 
treatment above the confirmed malaria rate in this study. The authors feel that full 
the potential of RDTs will only be achieved when better strategies to manage 
RDT-negative cases emerge. 
 Thiam et al. (2012) performed a study in remote villages of Senegal and 
attempted to demonstrate the feasibility of integrated use of RDTs for diagnosis 
and ACTs for treatment via a scale-up process from 2008 to 2010 using trained 
volunteer Home Care Providers (similar to CHWs). 93% of the 12,582 suspected 
cases were evaluated by Home Care Providers and 37% of patients had a 
positive RDT, so that 97% of those people were cured via antimalarials (Thiam et 
al., 2012).  
The training stated that if a patient was RDT negative or a more sensitive 
case, home care providers referred patients to health care facilities: 6,486 RDT 
negative patients, 119 infants, 105 pregnant women, and 161 severe cases were 
referred. Overall, incidence of in-hospital deaths attributed to malaria decreased 
significantly by 62.5%, while the decrease in the comparison group was slight 
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and not statistically significant (Thiam et al., 2012). Part of the reason for the 
success of this program in bringing effective malaria diagnosis to remote regions 
is that the Home Care Providers had an option to give a form of treatment to RDT 
negative patients, the option of referral. 
 In Ishengoma et al. (2011), 23,739 febrile cases were examined and 
18,217 of those cases were examined after RDT use had been implemented in 
an area of declining malaria prevalence in Tanzania by community-owned 
resource persons (similar to CHWs). These centers also had microscopy 
available. Only 27.8% of the 18,158 patients were tested for the malaria parasite 
with RDTs, however, of the RDT negative results 20.1% received AL treatment. 
Of the group that received antimalarials with negative RDT test results, 74.3% 
(3,154) were under the age of five and 3.4% (475) were over the age of 5. 
Despite this, RDTs greatly reduced the overtreatment using antimalarial 
dispensing from 98.9% of febrile cases to 32.1% of febrile cases in children 
under the age of 5 (Ishengoma et al., 2011). 
A key component of the training was how to identify which patients to treat 
and which patients to refer to the nearby health facility. Therefore, adherence by 
the community-owned resource persons to treatment guidelines was over 95% in 
cases from all age groups (Ishengoma et al., 2011). Adherence was very high 
since they were just following Tanzanian protocol, which stated to treat all febrile 
children under 5 with antimalarials irrespective of diagnostic result. 
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 In Chanda et al. (2011), they used CHWs for delivery of ACTs and RDTs 
in home management for malaria in two districts in Zambia from June 2008 until 
December 2009. There was excellent adherence: in the Chongwe district, 100% 
of RDT negative results were not prescribed an antimalarial and 99.4% in the 
Kalomo district. All RDT positive patients in both districts received an 
antimalarial. Most importantly, none of the negative RDT cases progressed to 
severe malaria and no deaths were recorded. Severe cases of malaria received 
referrals to a health facility for further management. Adherence in this trial is the 
best ever reported in Zambia. This was maintained even though there were large 
differences in malaria prevalence in the two districts: Chongwe district had 4.5% 
of its febrile cases diagnosed as malaria (257/5,648) while Kalomo had high 
malaria prevalence with 49.1% (2,061/4,199) of its febrile cases diagnosed as 
malaria.  
Training included practical sessions on how to use RDTs for malaria 
testing and how to interpret the result, essence of stock management, essence of 
infection prevention, and an emphasis placed on using the diagnostic result to 
inform the decision to prescribe an anti-malarial or not with referral mechanisms 
for severe malaria and non-malaria febrile cases. Of those not needing referral, 
the most common prescriptions involved painkillers, multivitamins, and de 
worming tablets. In these Zambian districts, care givers were happy with the 
services provided by the CHWs and their committed attention to patients, 
partially because in these areas community members recommend certain 
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individuals to be trained by health center personnel to work as a CHW. Since 
CHWs were so effective in this trial, if and when their case loads get higher due 
to success these volunteers may need compensation to maintain keeping up with 
the workload (Chanda et. al, 2011). Part of the reason for success is also that 
researchers gave the CHWs alternate treatments that they could use to help aid 
the patient, helping to ease the anxiety of sending a febrile patient away with no 
treatment if they receive an RDT negative result. The fact that the community 
helps to recommend CHWs may have added to the adherence of the CHWs 
since they community has already seen them as hardworking, diligent, patient, 
and intelligent. 
 Elmardi et al. (2009) executed a study in 20 villages of Sudan: volunteers 
(similar to CHWs) were trained one per village on how to use RDT for diagnosis 
and to treat them using artesunate plus sulphadoxine-pyrimethamine or refer the 
severe malaria cases and non-malaria cases between May 2007 and January 
2008. Their communities based on the study team’s important five characteristics 
chose these “Malaria Control Assistants”: availability in the area most of the time, 
acceptability by the community, reading ability, writing ability, and willingness to 
work as a volunteer. Pre- and post-intervention assessment involved household 
surveys, focus group discussions with community leaders, structured interview 
with the volunteers, and records and reports analysis (Elmardi et al., 2009).  
Use of RDT improved accuracy and trust in diagnosis, but 30% of 
volunteers  (6) did not rely on negative RDT results when treating fever cases but 
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instead relied on their clinical sense which equated fever with malaria. Therefore, 
those “Malaria Control Assistants” with experience in managing malaria or 
educated were less likely to rely on the RDT result. They treated 3,475 patients 
with 17.6% being under the age of 5 years and referred 0.9% of cases to the 
nearest hospital by diagnosing them as having another febrile condition and not 
malaria. There was no data regarding antimalarial prescriptions given to patients 
based on RDT results. Unfortunately, the project increased treatment-seeking 
behavior from 83.3% to 100% with the introduction of the CHWs (Elmardi et al., 
2009). Even though some programs may assume that CHWs do not have much 
background knowledge on malaria, some do and therefore will need some 
training to overcome their old diagnostic habits. 
 
Effect of Children Patients on Adherence 
In Ishengoma et al. (2011), Tanzanian guidelines were part of the reason 
that adherence was not as high as it could have been in the CHWs. Their reason 
for providing antimalarials to children less than 5 years when faced with an RDT 
negative result is that the most recent Tanzanian guideline when the study 
occurred was made in January 2007 when Tanzania changed its malaria 
guidelines due to the new ACTs on the market. This change stated AL should be 
prescribed to all febrile children less than 5 years irrespective of laboratory 
results while treatment of people over 5 years has to be based on laboratory 
conformation. 
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HOSPITAL WORKERS AND RAPID DIAGNOSTIC TESTS 
 
Study Designs, Results, and How Training Affected Adherence 
 Reyburn et al. (2007) was the first randomized clinical trial to examine if 
RDTs changed prescribing practices and lasted from January to August 2005, 
during which time 2,416 patients received RDT or microscopy for malaria testing 
in northeastern Tanzania. There was a high rate of malaria treatment for negative 
results in both groups: 86% of the 1,030 patients randomized to the microscopy 
group had a negative result but 51% were treated with an antimalarial, 84% of 
the 1,193 patients randomized to the RDT group had a negative RDT result but 
54% were treated for malaria. Overall, more than 90% of the prescriptions for 
antimalarial medicine in low-transmission areas were for patients that had a 
negative diagnostic test for malaria.  
The training they received was basic and did not seem to help them 
adhere to the RDT results. The training included discussion of RDTs and their 
high sensitivity and specificity and reviewed Tanzanian national malaria 
treatment guidelines which stated that a negative malaria test should allow a 
provider to think of alternative diagnoses to be considered (Reyburn et al., 2007). 
However, they were only told that alternative diagnoses should be considered, 
perhaps the providers considered others but did not act on them. An additional 
reason for massive over diagnosis of malaria and the lack of adherence may be 
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because physicians would use different tests for different patients, as opposed to 
there being a whole health facility effort to use one type of diagnostic tool. 
Hamer et. al, (2007) relates to a clinical trial in Zambia that surveyed 104 
health facilities, most had microscopy, RDTs, or more than one diagnostic test 
present. However, 58.4% of patients with negative blood smears received an 
antimalarial drug as well as 35.5% of negative RDT results. The febrile patients 
that did not have a diagnostic test performed received an antimalarial 65.9% of 
the time. Almost all of the patients with a positive microscopy and positive RDT 
result received an antimalarial. Overall, RDTs remain underused and many 
patients with negative RDT results inappropriately receive antimalarials.  
A few years later, Hamer et. al (2012) executed another clinical trial with 
an excellent training program. Training was given to 260 participants (clinical 
officers, nurses, environmental health technicians) in all 72 districts that included 
multi-language (English, Bemba, Nyanja) workshops, wall charts, and pictorial 
guides that gave participants knowledge on how to check RDT expiration dates, 
perform the test, and see if the test gave a positive, negative, or an invalid result. 
However, it did not provide recommendations on how to respond to a positive or 
negative result. The lack of giving the participants information on how to respond 
to conclusive results might have confused the participants. It is not that the 
workers do not understand the test, because the lowest rate they had in 
prescribing an antimalarial to a RDT positive case was 96.6%. Adherence to the 
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test result with RDT negative patients would have been higher if they had specific 
recommendations on how to respond to negative test results. 
 Masanja et al. (2010) exemplifies an instance of adherence in health 
workers in peripheral health facilities without microscopy. It involved 12 health 
facilities in Rufiji District, Tanzania where 30,195 patients were seen over an 11-
month span, and 35.6% of those patients acquired diagnosis with an RDT. 51.5% 
patients received RDT positive results, of which 98.6% were treated. 48.5% of 
patients were RDT negative and only 4% of them were treated with antimalarial 
medication (Masanja et al., 2010). 
The training, which involved local malaria epidemiology, the importance of 
RDTs, patient testing criteria, subsequent actions to follow with positive and 
negative RDT results, how to perform an RDT, practice reading and recording 
RDT results, and practice sessions on febrile patients and other health workers, 
can partially explain high adherence (Masanja et al., 2010). The guide on how to 
respond to RDT positive and negative results is most likely the training tool that 
most influenced the high adherence. 
 In the clinical study of Chinkhumba et al. (2010) in Blantyre, Malawi 2,576 
patients were tested with RDTs, and 58% of patients with negative RDT results 
were treated with antimalarials in sites without local microscopy. Training stated 
that patients with mixed microscopy negative, RDT positive cases should not 
receive treatment with antimalarials but 54% of providers still prescribed an 
antimalarial to those patients. 98% of patients with positive microscopy and RDT 
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results received an antimalarial prescription. 7% of patients who were both 
microscopy negative and RDT negative were still prescribed an antimalarial 
(Chinkhumba et al., 2010). 
All health workers received training- clinicians and nurses received one-
day refresher training on malaria diagnosis and treatment according to the new 
national malaria treatment guidelines. At the time of the study, the WHO 
recommended malaria management based on parasite-based diagnosis in all 
cases and the Malawi National Malaria Control Programme therefore developed 
new malaria treatment algorithms incorporating the use of RDT in patients over 5 
years for health facilities where malaria microscopy is not available (Chinkhumba 
et al., 2010). 
 The D’Acremont et al. (2011) RDT intervention involved a cluster-
randomized control analysis from January 2006 until September 2008 in Dar es 
Salaam, Tanzania. Three hospitals and 6 health facilities underwent the RDT 
intervention and 3 health facilities were matched as RDT-free controls. The 
positivity rate of microscopy used before the intervention was 49% and after 
intervention, the RDT positivity rate reduced to only 8% that is more in line with 
Tanzanian parasite prevalence using expert microscopy. RDT use greatly 
reduced AL prescription (68% in intervention group, 32% in control group) as well 
as quinine use (63% reduction in intervention group and 2.49 times increase in 
control group). This significant reduction is partly because there was excellent 
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adherence to the test result since only 7% of RDT negative patients received an 
antimalarial (D’Acremont et al., 2011).  
The training helps to explain why this group adhered well- it was 
presented as a pilot phase of national RDT deployment and health workers did 
not see it as an isolated research project. The audience additionally appreciated 
data detailing that malaria actually had a low prevalence in Dar es Salaam, that 
routine microscopy usually had bad quality, that RDTs performed excellently, and 
that RDTs help to combat mistrust between laboratory staff and clinicians.  
Unfortunately, a side of effect of adherence to RDTs involved antibiotic 
treatment increasing from 49% to 72%. However, there was no change in those 
facilities acute diagnosis of respiratory infection, pneumonia, diarrhea, and 
urinary tract infections   (D’Acremont et al., 2011) Therefore, to not simply move 
the over prescription of antimalarials to the over prescription of antibiotics, more 
training for the management of other causes of fever should be integrated into 
RDT learning. It would be a shame if RDT use augmented the problems of 
antibiotic resistance across the globe. Especially since there was not an increase 
in diagnosis of other fever causing illnesses that patients may have had instead. 
Skarbinski et al. (2009) performed a randomized trial where sixty Kenyan 
health facilities were either randomized to receive RDTs, training, guidelines, and 
supervision or randomized to receive just supervision. Of the 1,540 patients used 
in the analysis (2,004 patients enrolled), only 7% had uncomplicated malaria and 
AL treatment use only after laboratory confirmation reduced AL consumption by 
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63% (p = 0.03) since the health workers mostly adhered to RDT results (AL given 
to 88% of RDT positive results and 9% of RDT negative results). Unfortunately, 
this also reduced AL prescription to patients that did not have any diagnostic 
testing done on them, causing some uncomplicated malaria cases to go 
untreated. In the clinics chosen, about half also had microscopy available 
(Skarbinski et al., 2009). 
Training involved interactive discussion in small groups on RDT use, a 
presentation of the revised national malaria guidelines for outpatients over 5 
years, information on dosing, information on how to administer AL, and 
information on how to manage severe malaria. Revision of national malaria 
guidelines was that malaria is defined as fever (temperature over 37.5oC) within 
the last 48 hours with no apparent alternative cause such as soft tissue infection, 
urinary tract infection, ear infection, etc. (Skarbinski et al., 2009). 
Part of the success in adherence is that each individual health care facility 
had all of its providers use RDTs or had all of them not use RDTs. Again, this 
article shows that RDTs should be performed in all patients if possible to 
determine if they have malaria when presenting with fever, especially since it had 
the unintended adverse effect of lowering the prescription of AL to patients who 
did not have a diagnostic tool used on them when some of them did in fact have 
uncomplicated malaria. However, excessive use of RDT testing would undermine 
the cost savings that RDT can provide so research needs to be done to better 
understand why and when health workers order diagnostic tests. 
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Bisoffi et al. (2009) executed a randomized multi-center trial in 2006 in 
rural Burkina Faso, involving 852 febrile patients during the dry season and 1,317 
febrile patients in the rainy season who were individually randomized (about half 
and half) to receiving RDT or presumptive treatment. In the dry season RDT, 
testing was positive in 28.0% of cases and positive 68.2% of the time in the rainy 
season. However, 80.8% of the RDT negative results in the dry season were still 
diagnosed as having malaria and treated accordingly as were 85% of RDT 
negative results in the rainy season being diagnosed as having malaria and 
treated accordingly. This high percentage of patients being diagnosed with 
malaria despite the negative RDT result showed almost no difference from the 
diagnosis of malaria with presumptive treatment. Therefore, there was also no 
change in the diagnosis of other febrile causing illnesses in the RDT intervention 
arm (Bisoffi et al., 2009). 
The people who received training to perform the RDT tests on patients 
were research assistants who were recently graduated yet still employed junior 
nurses recruited to the study, and their training involved an intense 3 days where 
they learned study protocol and how to execute and read an RDT. Dispensary 
nurses also received training on RDT reading and RDT performance from 
literature. The main points given to both groups was that RDT negative result 
virtually excluded clinical malaria while a RDT positive result did not rule out 
fever being caused by other disease including malaria or in absence of malaria. 
Health workers were not told to refrain from malaria treatment in case of a 
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negative result, which the authors admitted was a major flaw in the study design. 
The nurses felt that the probability of malaria is so high that the disease presence 
remains likely even after a negative RDT result. Additionally, the authors point 
out that false positives with RDTs due to being a simple carrier of malaria 
parasites may make a provider think that the fever is due to malaria when it may 
be another disease such as pneumonia, this exact case happened to one child in 
their study (Bisoffi et al., 2009). 
The main fault of this training is that the treatment that both people in the 
control group and in the intervention group received was still to depend on 
national diagnostic guidelines, which were to treat all febrile cases as malaria 
until proven otherwise. These health providers did not see the new RDTs as 
sound evidence to prove otherwise for that old saying (fever equates malaria) 
and most likely contributed to the incredibly low adherence. Compliance was so 
low that the investigators could not even determine their goal of evaluating RDT 
safety. Additionally, use of RDT or presumptive treatment was by each patient 
and not by the whole health facility as a whole. The same research assistant may 
utilize presumptive treatment on one patient and RDT on another patient, limiting 
the importance of the new RDTs. In this study, they essentially ignored the RDT 
results. In addition, not all people giving the RDT results were trained to use it 
due to logistical problems. 
 Kyabayinze et al. (2010) examined how RDTs affected antimalarial 
prescriptions in Ugandan outpatients at low-level health care facilities with 
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different malaria epidemiological settings. 21 health facilities had all health 
workers were trained to use RDTs for all suspected malaria cases despite age. 
Five low-level health care facilities with clinical diagnosis only were used for 
comparison. Of the 166,131 people evaluated in the 21 intervention facilities, 
over 90% of eligible patients received an RDT; that is excellent since the health 
workers were only encouraged to use RDTs but not restricted to it. Overall, use 
of antimalarials went down 38%, with the greatest reduction in the hypo-endemic 
settings (greatest drop was 59% in the Kapchorwa district) but no significant 
change in the urban settings with hyper-endemic states of malaria. An average of 
30% of the RDT negative patients received an antimalarial and of these RDT 
negative group children less than five years of age were 2.6 times more likely to 
receive anti-malaria; 49% of children under five and 28% in people over 5 
received an antimalarial with an RDT negative result. 99% of the RDT positive 
group received an antimalarial. 
They also partook in in-depth interviews where 92% believed that RDT 
positive result confirmed malaria while only 49% believed an RDT negative result 
excluded malaria. After the one day training, 98% said they were committed and 
willing to perform RDTs on a daily basis to manage febrile outpatients. The 
health workers admitted during interviews that they sometimes treat RDT 
negative patients because they are afraid of the challenges of severe malaria 
because of the long distances to referral hospitals if the need arises. Other health 
workers stated that negative microscopy results do not exclude malaria due to 
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the possibility of sequestration of malaria parasites from peripheral blood, even 
though this does not apply to RDT, it may still attribute to the overall mistrust of 
negative results. Other thoughts by this group is that health workers found it 
socially acceptable to offer antimalarials to RDT negative patients and that since 
some health workers were unable to make a differential diagnosis they were 
more likely to give antimalarials so patients would appreciate the medical care 
(Kyabayinze et al., 2010).  
Training involved health workers (nursing assistants, nurses, clinical 
officers, and laboratory technologists) who were trained using the WHO training 
curriculum to understand parasite-based management of malaria, use of RDTs, 
record keeping, and waste disposal. In addition, training instructed them to test 
all presumed malaria cases with RDTs despite age or malaria endemicity setting. 
However, it also told them to give treatment according to the results and the 
Ministry of Health treatment guidelines which stated that “any patient with fever 
or history of fever within the last 24 hours without evidence of other disease 
should be treated for malarial even with a negative blood smear for malaria 
parasites” (Kyabayinze et al., 2010). An additional reason for less than ideal 
adherence is that this group did not have specific guidelines on what to do if it 
was not malaria. 
 Msellem et al. (2009) implemented a nonrandomized clinical trial involving 
four primary health care units in Zanzibar. Febrile patients were allocated to 
clinical diagnosis alone or clinical diagnosis with RDT diagnosis. 1,887 patients 
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were enrolled from February to August 2005, 55% of them being children under 
the age of 5. RDT use was associated with lower antimalarial prescription rates- 
36% (361/1,005) versus clinical diagnosis 85% (752/882) prescription rates. 
Additionally, antibiotic prescription rate was higher in RDT use periods, 37% use 
versus 27% use in the clinical diagnosis. Only patients diagnosed with malaria in 
both groups garnered an antimalarial prescription. The majority of antibiotics 
were prescribed to children below age 5 (65%) in the RDT with clinical diagnosis 
group versus the clinical diagnosis alone group (Msellem et al., 2009). 
The health care workers were registered nurses with 3 to 4 years of formal 
training where Malaria Control Programme and District Health management 
Teams of Ministry of Health trained them in diagnosis and treatment and in the 
IMCI algorithm. They additionally received one day training on the use of RDTs 
using the manufacturer’s instructions, encouragement to base antimalarial 
treatments on RDT results during RDT weeks, and received specific instructions 
to consider other treatments especially in RDT negative children while 
encouraging their guardians to return with the child if fever persisted. They also 
received instruction to prescribe other treatments in accordance with IMCI 
guidelines and their clinical judgment. Nurses expressed that the main reason to 
prescribe antimalarial drugs to patients with RDT negative results was fearing a 
false negative test result and being aware that delays in giving antimalarial 
treatment can be fatal (Msellem et al., 2009). One of the problems is that this 
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study did not encourage change to RDTs well since the participants switched 
between the old and the new methods.   
 
Prior Training Effect 
Part of the reason that primary health workers do not adhere to the results 
of RDTs is that throughout their training they learned that fever equates to 
malaria and they remain attached to that idea despite new trainings. Reasoning 
for this stems from a multitude of causes such as the health care workers think 
their knowledge remains smarter than the test and they have a mistrust for the 
test. This may even lead to higher morbidity and mortality because the true 
cause of the illness may be left untreated (Masanja et. al, 2010). 
Reasons for not following negative RDT results is that health providers 
feel reluctant to deviate from the sentiment that fever equates to malaria, a 
perceived lack of alternatives that requires educating health providers on 
alternatives, and that the drug has a low cost (Masaninga et al., 2012). 
Additionally, part of the reason for the mistrust regarding what laboratory 
technicians say when evaluating malaria diagnostic tools from clinicians is that 
the microscopy used is often poor so they have frequently erred on the side of 
caution and given antimalarials. Now, the user-friendly RDTs are much less likely 
to give inaccurate results since they do not require an expert to analyze the 
results and will potentially boost clinicians’ confidence. 
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Effect of Ambiguous International, National, and Local Guidelines on Adherence 
The WHO and other national guidelines have added to some of the 
confusion since they have stated in the past that malaria should be considered 
even if a patient has a negative RDT test result (D’Acremont et al., 2009). In 
general, CHWs do not know of these national guidelines as much although they 
may receive such knowledge during their RDT trainings, while hospital workers 
remain much more aware of them. In Reyburn et. al (2007), perhaps part of the 
failure is that they were told to re-look at ambiguous Tanzanian national malaria 
guidelines that said negative test results should simply allow other alternative 
diagnoses to be considered. Even if the ambiguity was not directly re-stated 
during the training sessions, it signaled for the providers to do what they had 
always done prior with the malarial diagnoses. 
In Chinkhumba et al. (2010), part of the low adherence to negative RDT 
test results (54% of patients with RDT negative results received an antimalarial) 
ensues from the Malawi National Malaria Control Programme which tried to 
incorporate use of RDT to determine diagnosis and treatment, but only in 
patients over the age of 5 at centers without microscopy. Although the article did 
not detail age differences, perhaps many of the participants who received an 
antimalarial when RDT negative were children less than 5 years. Additionally, 
many of the health facilities also did have microscopy and it has been shown that 
frequently hospital workers ignore negative slide results; perhaps they 
transferred that disregard of negative slide results to negative RDT results. 
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In Kyabayinze et al. (2010), the massive prescription of antimalarials to 
children under 5 when RDT was negative most likely stems from the IMCI 
strategy that Uganda had in 2007 at the time of the study. Additionally, training 
was under WHO guidelines that stress those febrile cases under 5 should be 
suspected as having malaria first and treated with antimalarials before other 
options receive consideration. In addition, the Ugandan guidelines also said that 
their workers could ignore results and still promoted presumptive treatment. 
The Bastiaens et al. (2011) trial saw the impact of antimalarial prescription 
to febrile outpatients under the age of 10 years at three hospitals in different 
districts (Sumve, Biharamulo, and Rubya) after a Tanzanian governmental policy 
change stating that antimalarial treatments should strictly be given to RDT 
positive individuals and RDT negative individuals should have alternative 
diagnoses looked for them. The study was purely observational and did not 
attempt to change clinical decisions; training simply explained the new 
government guidelines to medical officers in charge and the sensitivity of RDTs. 
Before this policy, there was no association between actual level of transmission 
intensity and drug-prescribing behavior, after the policy there was a substantial 
decrease in anti-malaria prescription. This article additionally provides an 
example that simple provision use of RDT before this Tanzanian policy change is 
another example of hospital workers not considering diagnostic results when it 
comes to malaria.  
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1,608 outpatients under the age of 10 years that presented to the 
hospitals from September 2009 – February 2010 were included for analysis. 
Antimalarial prescriptions for RDT parasite-negative individuals after the new 
policy change decreased from 89.1% (244/274) to 38.7% (46/119) in Biharamulo 
and from 76.9% (190/247) to 10.0% (48/479) in Rubya; it remained 68.1% in 
Sumve since it did not receive the training course but used as a comparison 
group. Parasite prevalence differed greatly among the groups with the lowest in 
Rubya (1-4%) and the highest in Sumve (42%). Participants prescribed 
antimalarial drugs to RDT positive patients in all cases. There was also an 
increase in antibiotic prescriptions: before the policy change in Biharamulo 12.8% 
of RDT negative patients received an antibiotic and afterwards 59.7%, in Rubya it 
similarly went up from 70.0% to 94.6%. The authors felt that this increase in 
antibiotic use meant that the clinicians were finding alternative diagnoses to 
malaria (Bastiaens et al., 2011). 
Although there was no formal training, the authors believe part of the 
success is having well trained and confident hospital staff, clear guidelines, and 
having constant availability of the needed resources (RDT, antimalarials, 
antibiotics); otherwise staff could return to their former diagnostic and 
prescription habits. The healthcare workers at these hospitals were mainly 
clinical officers with two to three years of clinical training. Hospital records 
indicate that common diagnoses for other conditions exist in their outpatients: 
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pneumonia, HIV, gastrointestinal infections, tuberculosis, malaria, and other 
parasite infections (Bastiaens et al., 2011). 
The governmental change also affected presumptive treatment for 
patients without an RDT, causing them to abandon it largely. Beforehand, in 
Biharamulo, 89% of patients without a slide taken were treated with an 
antimalarial, which went down to 27% after the policy change, this proportion 
changed from 67.5% to 2.0% in Rubya (Bastiaens et al., 2011). It is interesting 
that RDT use even affected presumptive treatment in these cases, which could 
even greater lower the risk of over prescription of antimalarials if people have an 
RDT stock out for example. However, it is dangerous if people presumptively 
think febrile cases are not malaria because it may cause missed cases; hospital 
workers should still definitely use an RDT to verify malaria. 
 
Effect of Children Patients on Adherence 
Part of the reason for the hesitance that providers face when withholding 
antimalarials from young children in both CHWs and hospital workers when they 
are RDT negative is because there is not much evidence that this approach 
proves safe (Hamer et al., 2012). On the other hand, other journal articles see 
that there is a potential that withholding treatment based on negative RDT results 
can be safe (Masaninga et al., 2012). 
D’Acremont et. al wrote a response to Reyburn et. al (2007) and note that 
part of the reason for lack of adherence was that guidelines from Tanzania state 
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that if results are negative and no signs of severe disease exist then children 
under age 5 should be treated as having uncomplicated malaria and to look for 
another condition, similar guidelines exist in Uganda (D’Acremont et. al, 2007). 
Overall, the idea that children under 5 years should receive malaria treatment 
irrespective of test results because the disease has a more rapid course in them 
is inadequate (D’Acremont et al., 2007). 
In Mtove et al. (2011), 965 children aged 3-59 months were enrolled over 
a one-year testing period of RDTs in a hospital that serves a rural population in 
Tanzania. 16.4% had an RDT positive result and all were treated with AL. 83.4% 
were RDT negative and were treated with non-anti-malarial medicines as per the 
study protocol. 47.5% of the RDT negative cases and 18.4% of the RDT positive 
children met WHO criteria for non-severe pneumonia and received amoxicillin 
treatment, additionally 4.2% of RDT negative, and 12% of RDT positive children 
met WHO criteria for non-severe pneumonia but did not receive amoxicillin. 
There was no evidence in terms of respiratory rate values to predict why there 
was prescriber confidence in withholding antibiotic treatment in the latter cases 
(Mtove et al., 2011). These health care providers already knew of pneumonia as 
an alternative reason for illness in febrile patients. 
Six (0.6%) of children became RDT positive after enrollment which 
diminished health care workers attitude that RDT worked well; it is not impossible 
to distinguish between new and missed diagnosis of malaria with routine follow-
up of RDT but in this case the investigators felt those 6 children were new cases. 
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To guard against  the strong preference diagnosis of malaria among parents and 
clinicians, and the perception from those groups that due to application of new 
guidelines of RDTs that a child was denied treatment, researchers should remind 
clinicians and parents that no test is perfect and to bring children back to the 
health center if they remain ill. This could lead to over diagnosis of non-severe 
pneumonia as per use of the IMCI guidelines especially since there is no gold 
standard for pneumonia diagnosis (Mtove et al., 2011). Overall, this study helps 
to prove the case that it is all right not to treat children with antimalarials when 
they are RDT negative because this study did not result in missed diagnoses of 
malaria. 
 
Effect of Microscopy Presence on Adherence 
 The hospital workers in Hamer et. al (2012) trusted the new RDTs more 
than microscopy since those clinicians were twice as likely not to prescribe 
antimalarials when having a negative RDT result as opposed to a negative blood 
smear with microscopy. Part of the reason for mistrusting or ignoring the results 
is that parasite detection usually gets performed by someone other than the 
prescriber (Hamer et al., 2012). 
In Masanja et al. (2010), part of the reason for the high adherence to not 
prescribe antimalarials after receiving an RDT negative result (only 4% received 
an antimalarial when RDT negative) may be because there was no other 
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microscopy or diagnostic tool to use. Therefore, they more heavily relied on the 
RDT.   
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DISCUSSION OF HOW TO IMPROVE ADHERENCE 
 
Many studies have examined the ability of CHWs and hospital workers to 
interpret the rapid diagnostic testing results with options on how to treat, which 
remains imperative. However, if a patient presents with fever and does not fit into 
the category of the few potential fever-causing illnesses that they received 
training about, both groups of workers may feel at a loss and prescribe malarial 
treatment. A methodology to combat this mistrust of negative results and 
assuage feelings of helplessness is to teach hospital workers and CHWs about 
other causes of fever besides malaria such as respiratory illnesses. Therefore, if 
they receive a negative result they do not have to feel guilty about not giving an 
antimalarial treatment if/when they find another disease to treat. An example of a 
good algorithm flow chart for them to follow (see Figure 7) is from Thiam et al. 
2012, which had excellent adherence. Hamer et. al (2012) is also an effective 
example of how training with alternate diagnoses algorithm flow charts helps to 
heighten adherence (see Figure 8). 
A proposed method is to make RDTs more widely available and to 
enhance quality control measures to raise confidence in the tests by health care 
providers. To increase use of CHWs in rural areas since they already adhere well 
and to increase their potential by designating health facilities in the area where 
CHWs can refer RDT negative patients. CHWs should be picked by people in 
their villages to ensure that they are of high quality. 
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Thiam et. al (2012) also suspects that maintenance of high adherence by 
Home Care Providers to RDTs stems from the gradual scale-up of RDT use in 
the region; this group also plans to train Home Care Providers to manage other 
fever producing illnesses such as pneumonia and diarrhea. One method is to 
make sure that in scale-up operations and clinical trials that everyone in a health 
facility should use RDT and not have, for example, the same physician use RDT 
on one patient but microscopy on another (D’Acremont et al., 2011). 
 
Figure 7: Algorithm Flow Chart for Fever Management by Home Care Providers. Taken from 
Thiam et al. 2012. 
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Figure 8: Classification and Treatment Algorithm Flowchart for Children Aged 6 Months to 
5 Years that Present with Fever and/or Cough/Difficult Breathing. Danger signs indicate 
immediate referral to the nearest healthcare facility. Taken from Hamer et al. 2012.
 
  
Malaria guidelines in the national and international scale need to become 
unambiguous and the new guidelines should be dispersed among the 
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community. A component of the new guidelines should include allowing denial of 
antimalarials to children when RDT negative. In regions where previous 
guidelines have been ambiguous, there should be advertising campaigns 
arranged to show the new changes. The new changes include the fact that 
malaria is declining in many areas and that fever does not equate to malaria as it 
did in the past due to many efforts to reduce malaria such as insecticides, larval 
control, insecticide-treated nets, etc. This will be beneficial when seen by hospital 
workers and CHWs, but also when seen by laypersons since it will make them 
less likely to request antimalarial treatments and to request antimalarial tests as 
frequently as they do now. 
 Additionally, a push to move from microscopy confirmed diagnostics to 
rapid diagnostic testing in all facilities, not just facilities that do not have adequate 
microscopy techniques, needs to happen in order to diagnose malaria succinctly. 
RDTs have a high sensitivity and high positive predictive value and prove useful. 
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CONCLUSION 
 
There is a discrepancy, especially in low endemicity settings, of perceived 
and actual malaria cases. The use of RDTs is especially important in areas of 
Africa that have declining malaria prevalence so that the prescription of 
antimalarials also declines with its reducing existence. The use of RDTs also 
seems like it could be most favorable in areas that have low endemicity ratings 
because the reduction in antimalarial prescriptions that they will have if they 
comply with RDTs will be massive. On the other hand, places that have a high 
malaria endemic rate will not see as much of a decline in malaria cases 
diagnosed and therefore may not see RDTs as useful since they will be 
confirming what they already thought.  
When different agencies first implemented the use of RDTs for malaria 
management, many assumed that providers would exactly follow the RDT result 
and treat patients accordingly but that simply was not the case. The groups must 
first deal with steadfast attitudes among many communities where fever equates 
to malaria even when presented with evidence to the contrary. Overall, effective 
implementation of RDTs requires an attitude change in health care providers on 
both the community and hospital level. 
In general, health care providers give antimalarial with positive RDT 
results in essentially a 1:1 ratio, it is only when faced with a negative RDT result 
that adherence begins to falter. In order to improve this, cascade models seem to 
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be effective as well as gradually introducing RDTs into practice so as to maintain 
efficient use of RDTs. Good training helped to decrease antimalarial prescribing 
to negative result patients but never as much in hospital workers as CHWs 
prescribe. 
Trained clinicians and health care workers are more reluctant to adopt the 
changed protocols that RDT brings because they feel that they already know a 
lot about the malaria subject. Part of the reason for high adherence in CHWs is 
that in their training they were more likely to be offered options to take if the RDT 
result was negative. Additionally, they adhere better than hospital workers do 
because hospital workers do not have anyone to refer the patients to, they are 
the referral, and that poses a lot of pressure to try to prove the symptoms of the 
patient. Overall, training was not that different between CHWs and hospital 
workers but with the hospital workers, a lot more prior knowledge needs 
overcoming before they adhere to RDT results. It is not so much that CHWs 
adhere to RDT results in spite of their lack of overall medical training but that 
they adhere to RDT results precisely because of this lack of overall medical 
training. 
Perhaps the presence of multiple diagnostic tools at hand makes it more 
difficult to adhere to the RDT result. Of course, a solution to this would not be to 
limit the use of microscopy in order to boost RDT adherence, especially when it 
should be used in combination to confirm one another. It might be beneficial to 
give extra training to health care facilities that are fortunate to have both 
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diagnostic tools on the benefit of adhering to RDTs. This discrepancy could be 
because microscopy is expensive and health care facilities that have both 
options have more highly paid and well-trained physicians who have more 
medical training and may feel more reluctant to change their methodologies. 
The future direction of malaria management needs to improve malaria 
treatment in Africa by limiting patients’ exposure to antimalarial side effects 
unnecessarily, reduce resistance to antimalarial drugs, find alternative febrile 
causing diseases to treat them, and to improve cost. The use of rapid diagnostic 
testing is an excellent way to accomplish that. 
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